MYDGF is a promising target to reverse cardiac remodeling and HF because, in mice models, recombinant MYDGF protein improves heart regeneration both in neonatal and adult heart after MI or TAC injury [182,184,185]. This evidence concerns the gene MYDGF and myocardial infarction.